BioSpace News Archive

Innovative in-vitro models ready-to-use for safety, ADME, and toxicology studies in drug development and food & nutrition research.

The international botulinum toxin market is gigantically advantaged by the soaring number of applications for different purposes.

The worldwide collagen market is prognosticated to turn out to be significantly profitable in coming years.

According to a recently published report by Future Market Insights, the global drug of abuse testing market was valued at US$ 1.3 Bn in 2019.

According to a report by Transparency Market Research, the global cleanroom consumable market is expected to rise at a healthy CAGR of 4.15% during 2017 to 2023.

Karyopharm Therapeutics posted positive Phase III results in multiple myeloma and announced it is planning a regulatory submission in the second quarter of this year for its combination of Xpovio, Velcade and Dexamethasone.

In addition, the company’s chief scientific officer, Seth Ettenberg, has resigned.

MorphoSys AG announced that the U.S. Food and Drug Administration accepted filing of MorphoSys’ Biologics License Application and granted priority review for tafasitamab, the Company’s investigational anti-CD19 antibody, under review in combination with lenalidomide for the treatment of relapsed or refractory diffuse large B cell lymphoma.The FDA has set a Prescription Drug User Fee Act goal date of August 30, 2020.

Olaris’ metabolite profiling platform and machine learning algorithms have the potential to accurately indicate whether HER2-positive metastatic breast cancer patients will respond to trastuzumab therapy

The report details an exhaustive account of the global healthcare chatbots market along with numerous associated factors.